Valion Bio, Inc.
VBIO
$1.10
-$0.01-0.90%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.65M | 3.45M | 1.18M | 669.00K | 2.00M |
| Total Receivables | -- | 19.00K | 148.00K | 13.00K | -- |
| Inventory | -- | 4.00K | 283.00K | 306.00K | -- |
| Prepaid Expenses | 346.00K | 44.00K | 227.00K | 273.00K | 240.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.00K | 223.00K | -- | -- | 397.00K |
| Total Current Assets | 13.01M | 3.74M | 1.84M | 1.26M | 2.64M |
|
|
|||||
| Total Current Assets | 13.01M | 3.74M | 1.84M | 1.26M | 2.64M |
| Net Property, Plant & Equipment | 12.64M | 12.00K | 120.00K | 118.00K | 2.00K |
| Long-term Investments | 3.46M | -- | -- | -- | -- |
| Goodwill | 3.46M | -- | -- | -- | -- |
| Total Other Intangibles | 2.24M | 2.24M | 2.24M | 2.23M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 260.00K | 234.00K | 303.00K | 172.00K | 166.00K |
| Total Assets | 31.61M | 6.23M | 4.51M | 3.78M | 2.81M |
|
|
|||||
| Total Accounts Payable | 264.00K | 465.00K | 234.00K | 438.00K | 125.00K |
| Total Accrued Expenses | 376.00K | 170.00K | 587.00K | 303.00K | 132.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 6.00K | 3.00K | -- | -- | 15.00K |
| Total Other Current Liabilities | 6.00K | 3.00K | -- | -- | 15.00K |
| Total Current Liabilities | 646.00K | 638.00K | 821.00K | 741.00K | 272.00K |
|
|
|||||
| Total Current Liabilities | 646.00K | 638.00K | 821.00K | 741.00K | 272.00K |
| Long-Term Debt | 6.45M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.71M | -- | -- | -- | -- |
| Total Liabilities | 14.81M | 638.00K | 821.00K | 741.00K | 272.00K |
|
|
|||||
| Common Stock & APIC | 69.39M | 55.21M | 50.66M | 48.08M | 46.08M |
| Retained Earnings | -52.60M | -49.62M | -46.98M | -45.04M | -43.54M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 16.80M | 5.59M | 3.69M | 3.04M | 2.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.80M | 5.59M | 3.69M | 3.04M | 2.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.80M | 5.59M | 3.69M | 3.04M | 2.54M |
|
|
|||||